“Why Does Psychiatry So Often Get a Free Pass on Standards of Evidence?”
Rob Wipond takes HealthNewsReview.org to task for its coverage of a Philadelphia Inquirer article about a medical device designed for people experiencing panic. He writes that “hyperbolic psychiatric and psychological claims frequently get free passes from otherwise thoughtful medical critics.”
“As Opioid Deaths Reach Record High, Drug Industry Resists Efforts to Rein in Prescriptions”
“In 2014, the number of people who died from drug overdoses in the United States reached 47,055 — an all-time high, according to a disturbing report published Friday by the Centers for Disease Control and Prevention (CDC),” but “the effort to get physicians to curb their prescribing of these drugs may be faltering amid stiff resistance from drugmakers, industry-funded groups and, now, even other public health officials.”
“Children Today Suffer From a Deficit of Play”
Boston College Psychologist Peter Gray writes for Aeon about the impact of the gradual erosion of children’s’ play in the United States. “Over the...
Antidepressants, Pregnancy, and Autism: Why Wouldn’t Antidepressant Chemicals Affect a Developing Baby’s Brain?
This week another study was published showing that SSRI antidepressant use during pregnancy is associated with increased rates of autism in the children. By my count, this is now the tenth study on this topic and it follows on the heels of previous studies – all of which found links between SSRI antidepressant use in pregnancy and autism in the offspring. Most of these studies were recently reviewed by Man, et al, who also concluded that SSRI antidepressant use during pregnancy is associated with autism in the children. So we now have numerous studies in different human populations all showing a link between SSRI use in pregnancy and autism in the children. Yet, much of the news and blogosphere focus on casting doubts about these findings. What is going on here?
“When Pills Are the Problem”
In the context of the Silicon Valley suicides, one mother offers her story about her daughter. “It’s my premise that not only the culture of Silicon Valley, but also, almost more importantly, the nature of the remedies that are being proposed in the name of mental health counseling, are to blame in these deaths.”
“Culturally Specific Treatment Center Knows That One Approach Doesn’t Work for All”
"What was going on inside Turning Point was an experiment: a community-based treatment center designed to serve low-income African-Americans. After a few bumpy early...
“Psychiatric Drug—Not Antibiotic—Messes with Gut Microbes, Spurs Obesity”
In a series of experiments in mice, researchers found that the drug risperidone alters gut microbes, which in turn profoundly influence metabolism, weight, and overall health.
“How to Find Meaning in Suffering”
In Scientific American, Kasley Killam presents insights from research on “post-traumatic growth,” highlighting the importance of finding meaning or underlying significance in our struggles and misery. “The psychiatrist and Holocaust survivor Viktor Frankl wrote extensively about this process after observing that his fellow inmates in concentration camps were more likely to survive the horrific conditions if they held on to a sense of meaning.”
“Warning Over Ketamine Use for Depression”
The Daily Telegraph reports on a warning published in the Medical Journal of Australia that urges doctors not to “jump the gun in prescribing patients the drug ketamine to treat depression.”
Antidepressants Associated with Increased Risk for Manic Symptoms
An analysis of medical records in the UK reveals that the use of certain antidepressants for depression is linked to a heightened risk for mania and bipolar disorder. The research, published this week in BMJ Open, found the strongest effect for serotonin reuptake inhibitors (SSRIs) and the antidepressant venlafaxine.
Book Review: “Overmedicated and Undertreated”
A former pharma executive has broken ranks with the industry in a new book by reporting how multiple psychiatrists, schools, and his desperate hopes pressed him to allow higher and higher doses of antipsychotic medications. The result: his 15-year-old son's death from Seroquel.
“Pharmaceutical Prosthesis and White Racial Rescue in the Prescription Opioid ‘Epidemic’”
Critical psychiatry researcher, anthropologist and NYU professor Helena Hansen writes: “Opioid maintenance acts as a kind of pharmaceutical prosthesis which promises to return white ‘addicts’ to regaining their status as full human persons and middle-class consumers. Meanwhile, black and brown users are not deemed as persons to be rescued, but rather dangerous subjects to be pharmaceutically contained within the public discipline of the state.”
Maternal Antidepressant Use Tied to Autism
In a major study, published yesterday in JAMA Pediatrics, the use of SSRI antidepressants during pregnancy was found to increase the risk of autism spectrum disorder (ASD) by 87-percent. Previous studies reveal that more than 13-percent of women currently use SSRI antidepressants during pregnancy.
“Autism’s Lost Generation”
“Some autistic adults have spent much of their lives with the wrong diagnosis, consigned to psychiatric institutions or drugged for disorders they never had,” Jessica Wright writes in The Atlantic.
Bullying & its Long-Term Effects on Wellness
Psychologist William Copeland writes for Mental Health Recovery that “bullying can occur at any age and the effects of which remain harmful long after the behavior has been endured.” “We, as a society, are just beginning to understand and come to terms with the havoc that bullying wreaks on the emotional lives of its victims.
Terrorism Science: 5 Insights into Jihad in Europe
"Terrorism researchers are trying to understand how young people in Europe become radicalized, by looking for clues in the life histories of those who have committed or planned terrorist acts in recent years, left the continent to join ISIS, or are suspected of wanting to become jihadists. A mixture of sociologists, political scientists, anthropologists and psychologists, such researchers are drawing on information generated by police, judicial inquiries and the media, and, in some cases, on interviews. They also study factors at play in prisons and socially-deprived areas. Some of their insights are summarized here.”
Pfizer Gets FDA Approval For Chewable Ritalin
Yesterday, the FDA approved Pfizer's “QuilliChew ER” chewable methylphenidate for ADHD in children as young as six. “CNS stimulants, including Quillivant XR, QuilliChew ER, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence.”
“Stem Cells to Treat Depression?”
A phase 1 study for a stem cell derived agent that promotes the growth of new nerve cells in the brain demonstrated efficacy in a very small sample of patients diagnosed with major depressive disorder (MDD). The phase 1B study was published online December 8 in Molecular Psychiatry.
43% Increase in ADHD Diagnoses among School-Aged Children in US
Citing a 43 percent jump since 2003, researchers estimate that 5.8 million school-aged children and teens in the US now have an ADHD diagnosis, a staggering 12 percent of this population. The new NIH-funded analysis also found that the percentage of girls diagnosed with ADHD was up 55% and that the percentage of Hispanic children diagnosed shot up 83% over the same timeframe.
Antidepressants Not More Effective Than Therapy for Major Depression
A new study, published this week in BMJ, found no major differences in the effectiveness of cognitive behavioral therapy (CBT) and antidepressants. When the researchers compared previous studies, they found no major differences in relapse rates or level of treatment response between those taking antidepressants and those undergoing CBT.
“Psychiatric Drugs Are Being Prescribed to Infants”
The New York Times reports that a growing number of infants and toddlers are being prescribed dangerous psychiatric drugs. “Almost 20,000 prescriptions for risperidone (commonly known as Risperdal), quetiapine (Seroquel) and other antipsychotic medications were written in 2014 for children 2 and younger, a 50 percent jump from 13,000 just one year before.”
REFOCUS Psychosis Recovery Intervention Ready for Trials
A new pro-recovery manualized intervention – called the REFOCUS intervention – has been developed and will now be evaluated in a multisite randomized control trials. The strengths-based intervention, which focuses on promoting relationships, is outlined in the latest issue of the British Journal of Psychiatry.
“An Accused Murderer Is Trying to Use a Brain Scan as Evidence He Couldn’t...
Philip Chism, who at 14-years-old brutally assaulted and murdered his teacher at Danvers high school in Massachusetts, has attempted to mount an insanity defense by producing brain scans that his expert witnesses have connected to schizophrenia. The judge has dismissed this evidence, however. “The inference the jury was asked to draw was that the volumetric value of the brain [is] consistent with schizophrenia is that the defendant has schizophrenia,” he said. “That is simply an impermissible inference for the jury to draw.”
“4 in 10 Know Someone Addicted to Prescription Pain Killer”
A new poll, published in the Washington Post, explores the public’s connection to prescription pain killer abuse. “A surprising 56 percent of the public say...
Depression Discrimination More Severe in High Income Countries
According to a study published in this month’s British Journal of Psychiatry, people diagnosed with depression in high-income countries are more likely to limit...